# Cytoprotective Mechanism of Necrox-5 Against Toxicity Induced by Experimental Ferroptosis Instigators and the Pesticide Propargite

**Authors:** Md. Jakaria, Jason R. Cannon

PMC · DOI: 10.3390/ijms27041772 · International Journal of Molecular Sciences · 2026-02-12

## TL;DR

This study shows that Necrox-5 protects cells from ferroptosis and pesticide toxicity by acting as a powerful antioxidant.

## Contribution

The paper is the first to demonstrate Necrox-5's protective effects against ferroptosis and propargite-induced toxicity.

## Key findings

- Necrox-5 inhibits ferroptosis caused by multiple inducers like erastin and RSL3.
- Necrox-5 protects against propargite toxicity but does not restore GSH or ATP levels.
- Radical-scavenging antioxidant activity is the main mechanism of Necrox-5's cytoprotection.

## Abstract

Necrox-5 is an indole-derived antioxidant that inhibits necrotic cell death, likely through prevention of mitochondrial stress, oxidative stress, inflammation, and hypoxia/reoxygenation. However, its protective role against ferroptotic toxicity has not yet been studied. In this study, we induced ferroptosis in HT-22 cells, an immortalized hippocampal neuronal cell line, using ferroptosis-inducing agents. We also tested Necrox-5 against toxicity induced by propargite, a pesticide known to inhibit complex V (mitochondrial adenosine triphosphate [ATP] synthase) and induce necrosis. We evaluated cytotoxicity using calcein AM and lactate dehydrogenase (LDH) release assays. Additionally, we conducted intracellular and cell-free C11-BODIPY assays to assess the efficacy of Necrox-5 in inhibiting lipid peroxidation. Intracellular glutathione (GSH) levels were measured using the mBCI-GSH assay, while ATP levels were determined through bioluminescence assays. Our findings show that Necrox-5 is a potent inhibitor of ferroptosis induced by erastin, RSL3, FINO2, and iron plus arachidonic acid. Furthermore, we demonstrated that Necrox-5 protects against ferroptosis-like propargite toxicity, although it did not prevent propargite-induced depletion of GSH and ATP. We identified radical-scavenging antioxidant activity as the primary mechanism by which Necrox-5 protects from ferroptosis and propargite toxicity. In conclusion, Necrox-5 is a potent cytoprotective compound that warrants further study for its potential role in ferroptosis-associated complications such as neurodegenerative diseases.

## Linked entities

- **Chemicals:** propargite (PubChem CID 4936), erastin (PubChem CID 11214940), RSL3 (PubChem CID 1750826), FINO2 (PubChem CID 23815485), arachidonic acid (PubChem CID 444899), glutathione (PubChem CID 124886), ATP (PubChem CID 5957)

## Full-text entities

- **Genes:** Ppfia1 (protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1) [NCBI Gene 233977] {aka C030014K08Rik, LIP.1, LIP1}, ppargc1a (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) [NCBI Gene 553418] {aka PGC-1, PGC-1alpha, PGC1, gb:dq017637, ppargc1al}, Hpgds (hematopoietic prostaglandin D synthase) [NCBI Gene 54486] {aka H-PGDS, Ptgds2}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, th (tyrosine hydroxylase) [NCBI Gene 30384]
- **Diseases:** neurotoxicity (MESH:D020258), mitochondrial dysfunction (MESH:D028361), PD (MESH:D010300), inflammation (MESH:D007249), injury to (MESH:D014947), neurodegenerative diseases (MESH:D019636), calcium overload (MESH:D019190), cardiac hypoxia (MESH:D000860), anaphylaxis (MESH:D000707), motor deficits (MESH:D009461), respiratory distress (MESH:D012128), acute (MESH:D000208), Cytotoxicity (MESH:D064420), retinal degeneration (MESH:D012162), reperfusion injury (MESH:D015427), necrosis (MESH:D009336), pulmonary fibrosis (MESH:D011658)
- **Chemicals:** D-luciferin (MESH:C532924), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), carbon (MESH:D002244), lipid hydroperoxides (MESH:D008054), IGEPAL CA-630 (MESH:C010615), sulfone (MESH:D013450), Propargite (MESH:C002771), oxygen (MESH:D010100), C11-BODIPY 581/591 (MESH:C120421), ferrostatin-1 (MESH:C573944), Calcein AM (MESH:C085925), galactose (MESH:D005690), Ag (MESH:D012834), BODIPY (MESH:C095489), liproxstatin-1 (MESH:C000595890), bleomycin (MESH:D001761), Iron (MESH:D007501), AA (MESH:D016718), indole compounds (MESH:D007211), vitamin A (MESH:D014801), phospholipid (MESH:D010743), amine (MESH:D000588), thiols (MESH:D013438), amphotericin B (MESH:D000666), MNU (MESH:D008770), monochlorobimane (MESH:C059597), NecroX-5 (MESH:C574766), cystine (MESH:D003553), penicillin (MESH:D010406), Erastin (MESH:C477224), 1,2-dioxolane (-), sulfur (MESH:D013455), indole (MESH:C030374), DMSO (MESH:D004121), glucose (MESH:D005947), neomycin (MESH:D009355), BSO (MESH:D019328), N-acetylcysteine (MESH:D000111), ABTS (MESH:C002502), Lipid (MESH:D008055), lipopolysaccharide (MESH:D008070), 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MESH:D015632), calcein (MESH:C007740), ATP (MESH:D000255), GSH (MESH:D005978)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Danio rerio (leopard danio, species) [taxon 7955]
- **Cell lines:** HT-22 — Mus musculus (Mouse), Transformed cell line (CVCL_0321), HT-4 — Mus musculus (Mouse), Transformed cell line (CVCL_U378)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941267/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941267/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941267/full.md

---
Source: https://tomesphere.com/paper/PMC12941267